Literature DB >> 7952459

Patient characteristics, methods of diagnosis, and treatment of mucous membrane melanoma in the United States of America.

C M Sutherland1, J S Chmiel, D E Henson, D P Winchester.   

Abstract

BACKGROUND: There is limited information regarding mucous membrane malignant melanoma. STUDY
DESIGN: The American College of Surgeons performed a patient care and evaluation study of malignant melanoma for 1981 and 1987 to determine the presenting symptoms, methods of evaluation, clinical management, and disease outcome. Previous reports on malignant melanoma of the skin and ocular melanoma have been prepared. This report details the findings for 60 patients with mucous membrane melanoma diagnosed in 1981 and 97 patients diagnosed in 1987.
RESULTS: The patients with mucous membrane melanoma were generally older than patients with either skin or ocular melanoma. Significantly more females than males were reported, with no significant change between study years. Proportionally, more blacks were diagnosed with this condition than in the previous studies of skin and ocular melanoma. The patients with melanoma in this study had a poor prognosis based on characteristics known to be important for skin melanoma. As for patients with skin melanoma, most patients with mucous membrane melanoma were treated with operation alone, but good results were infrequent in patients with mucous membrane melanoma. Local, regional, and systemic recurrences were significant problems and overall survival was poor.
CONCLUSIONS: We need new methods of treating these patients to control the disease and improve survival rates.

Entities:  

Mesh:

Year:  1994        PMID: 7952459

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  8 in total

1.  Malignant gastrointestinal melanomas of unknown origin: should it be considered primary?

Authors:  A Manouras; M Genetzakis; E Lagoudianakis; H Markogiannakis; A Papadima; G Kafiri; K Filis; P-B Kekis; V Katergiannakis
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

2.  Immune checkpoint inhibitors in the treatment of advanced mucosal melanoma.

Authors:  James C Kuo
Journal:  Melanoma Manag       Date:  2017-10-04

3.  Bleeding Beyond the Line: Anorectal Melanoma as a Cause of Lower Gastrointestinal Bleeding.

Authors:  Huy D Phan; Hongying T Tan; James H Tabibian
Journal:  J Gastrointest Cancer       Date:  2020-11-18

Review 4.  [Anorectal melanoma. A rare and highly malignant tumor entity of the anal canal].

Authors:  B M Helmke; H F Otto
Journal:  Pathologe       Date:  2004-05       Impact factor: 1.011

5.  A rare case of rynopharyngeal melanoma.

Authors:  Francesco Grecchi; Stefano Podrecca; Ilaria Zollino; Valentina Candotto; Francesco Gallo; Giuseppe Rubino; Raffaella Bianco; Francesco Carinci
Journal:  Dent Res J (Isfahan)       Date:  2012-12

6.  Epidemiology and outcomes of gastrointestinal mucosal melanomas: a national database analysis.

Authors:  Niraj James Shah; Mark M Aloysius; Eldrin Bhanat; Shweta Gupta; Ganesh Aswath; Savio John; Shou-Jiang Tang; Hemant Goyal
Journal:  BMC Gastroenterol       Date:  2022-04-09       Impact factor: 3.067

7.  Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence.

Authors:  Kevin O'Regan; Micheál Breen; Nikhil Ramaiya; Jyothi Jagannathan; Pamela J DiPiro; F Stephen Hodi; Annick D Van den Abbeele
Journal:  Cancer Imaging       Date:  2013-12-30       Impact factor: 3.909

Review 8.  Melanoma epidemiology, biology and prognosis.

Authors:  Z Ali; N Yousaf; J Larkin
Journal:  EJC Suppl       Date:  2013-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.